We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Rheumatology

Annals of Medicine

In the Rheumatology section of Annals of Medicine we consider for publication the latest advances in:

Adult Disease Ankylosing Spondylitis Biologics Clinical Outcomes
Disease Management Disease Progression Epidemiology Pathogenesis
Pediatric Disease Psoriatic Arthritis Rheumatoid Arthritis Treatment of Inflammatory Conditions
Annals of Medicine

Q1 Rank

Two-Year Impact Factor 3.243
Five-Year Impact Factor 3.840

MEDLINE® Indexed

CiteScore 5.70

Editorial Board Member for Annals of Medicine

Meet the Section Editor

Dae Hyun Yoo, Professor of Rheumatology , Department of Internal Medicine, Division of Rheumatology, Hospital for Rheumatic Disease, Hanyang University School of Medicine, Seoul, Korea

After completing his Rheumatology Fellowship Training and PhD Theses in South Korea, Professor Dae Hyun Yoo moved to the Hopsital for Special Surgery, New York where his research focused on the etiology and management of systemic lupus erythematosus. Professor Yoo has served as President and Chair of the Board of Korean College of Rheumatology and Vice President of the Asia Pacific League of Associatioins for Rheumatology (APLAR). Currently he continues to research the pathogenesis and management of Adult Onset Still's Disease, inflammatory myositis, rheumatoid arthritis, the challenges of the prevention and subsequent management of biologic-related opportunistic infections and the development and use of biosimilar drugs for the treatment of rheumatic diseases.

Why is Annals of Medicine the Best Publication for Your Research?

Fully open access, general medical journal publishing articles under a CC BY license, allowing maximum sharing and reuse of articles to our international readership;

Publishing all scientifically valid research, including reporting of negative and null data, from translational to clinical research in all disciplines and therapy areas;

Led by an international editorial team of subject experts who ensure a constructive and rigorous peer review process;

Your research is promoted via a tailored, multi-channel approach to maximize visibility, readership and impact.

Read the Journal          Article Alerts          Submit Now